TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL DRUG COATED BALLOON CATHETER MARKET, BY TYPE
6.1. Overview
6.2. Paclitaxel
6.3. Sirolimus
7. GLOBAL DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT
7.1. Overview
7.2. Coronary Artery Disease
7.3. Peripheral Vascular Disease
8. GLOBAL DRUG COATED BALLOON CATHETER MARKET, BY END-USER
8.1. Overview
8.2. Hospital
8.3. Clinics
8.4. Ambulatory Surgical Centers
9. GLOBAL DRUG COATED BALLOON CATHETER MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Drug Coated BALLOON Catheter Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Drug Coated BALLOON Catheter Market,
10.7. Key Developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger &Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income,2023
10.8.2. Major Players R&D Expenditure.2023
11. COMPANY PROFILES
11.1. Bayer AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. B. Braun SE
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Eurocor GmbH
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Biosensors International Group
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Boston Scientific Corporation
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. iVascular
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Medtronic plc
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. BIOTRONIK
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Caliber Therapeutics
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Concept Medical Research
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL DRUG COATED BALLOON CATHETER MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL DRUG COATED BALLOON CATHETER MARKET, ESTIMATES &FORECAST, 2019-2032(USD BILLION)
TABLE 3 GLOBAL DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 US: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 US: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 11 US: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 12 CANADA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 13 CANADA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 CANADA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 10 ITALY: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 11 ITALY: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 ITALY: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 16 UK: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 17 UK: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 UK: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 28 CHINA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 29 CHINA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 CHINA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 31 INDIA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 INDIA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 33 INDIA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: DRUG COATED BALLOON CATHETER MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: DRUG COATED BALLOON CATHETER MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: DRUG COATED BALLOON CATHETER MARKET, BY END-USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DRUG COATED BALLOON CATHETER MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DRUG COATED BALLOON CATHETER MARKET
FIGURE 4 GLOBAL DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY TYPE, 2023
FIGURE 5 GLOBAL DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 6 GLOBAL DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY END-USER, 2023
FIGURE 7 GLOBAL DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: DRUG COATED BALLOON CATHETER MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL DRUG COATED BALLOON CATHETER MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BAYER AG: SWOT ANALYSIS
FIGURE 15 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 B. BRAUN SE: SWOT ANALYSIS
FIGURE 17 EUROCOR GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 EUROCOR GMBH: SWOT ANALYSIS
FIGURE 19 BIOSENSORS INTERNATIONAL GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 BIOSENSORS INTERNATIONAL GROUP: SWOT ANALYSIS
FIGURE 21 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 23 IVASCULAR: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 IVASCULAR: SWOT ANALYSIS
FIGURE 25 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 27 BIOTRONIK: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 BIOTRONIK: SWOT ANALYSIS
FIGURE 29 CALIBER THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 CALIBER THERAPEUTICS: SWOT ANALYSIS
FIGURE 31 CONCEPT MEDICAL RESEARCH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 CONCEPT MEDICAL RESEARCH: SWOT ANALYSIS